Literature DB >> 31396326

In vivo evaluation of callispheres microspheres in the porcine renal artery embolization model.

Baosheng Ren1,2, Wansheng Wang1, Jian Shen1, Caifang Ni1, Xiaoli Zhu1.   

Abstract

This study aimed to evaluate the operational performance, embolization effect and safety of CalliSpheres microspheres (CSM) in a porcine renal model. 24 healthy normal pigs were randomized into CSM group and Embosphere microspheres (ESM) group equally, and embolized with CSM or ESM in the lower pole of right kidneys, respectively. On D2, D7 and D28 after the operation, angiography and biochemistry examination were performed, and then the pigs were subjected to renal macroscopic and histopathological examination after euthanasia (4 pigs/group per each time point). The embolization was performed successfully in all pigs without obvious adverse events or deaths, and there was no difference in operation assessments (including number of embolized arteries, volume of injected microspheres and vessel recanalization rate) between CSM group and ESM group. After the operation, all pigs in CSM group and ESM group presented with renal necrosis, stasis and capsule exudation on D2 and D7, and capsule thickening, fibrosis and renal atrophy on D28, and there was no difference in these macroscopic or microscopic manifestations between two groups. For biochemistry indexes (including blood routine, coagulation function, liver function and renal function), most of them were similar between two groups at each time point. CSM embolizes porcine renal artery effectively and safely without obvious adverse events or deaths, which might be a good option for embolization therapy in clinical practices.

Entities:  

Keywords:  CalliSpheres microspheres; effectivity; necrosis; renal artery embolization; safety

Year:  2019        PMID: 31396326      PMCID: PMC6684889     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  29 in total

1.  Experimental liver embolization with four different spherical embolic materials: impact on inflammatory tissue and foreign body reaction.

Authors:  Ulrike Stampfl; Sibylle Stampfl; Nadine Bellemann; Christof-Matthias Sommer; Ruben Lopez-Benitez; Heidi Thierjung; Boris Radeleff; Irina Berger; Goetz M Richter
Journal:  Cardiovasc Intervent Radiol       Date:  2009-01-13       Impact factor: 2.740

2.  Do microspheres with narrow or standard size distributions localize differently in vasculature? An experimental study in sheep kidney and uterus.

Authors:  Alex Laurent; Elodie Velzenberger; Michel Wassef; Jean-Pierre Pelage; Andrew L Lewis
Journal:  J Vasc Interv Radiol       Date:  2008-10-23       Impact factor: 3.464

3.  Comparative study of four different spherical embolic particles in an animal model: a morphologic and histologic evaluation.

Authors:  José I Bilbao; Esther de Luis; José A García de Jalón; Alba de Martino; María D Lozano; Antonio Martínez de la Cuesta; Bruno Sangro
Journal:  J Vasc Interv Radiol       Date:  2008-09-26       Impact factor: 3.464

4.  Arterial distribution characteristics of Embozene particles and comparison with other spherical embolic agents in the porcine acute embolization model.

Authors:  Sibylle Stampfl; Nadine Bellemann; Ulrike Stampfl; Christof M Sommer; Heidi Thierjung; Ruben Lopez-Benitez; Boris Radeleff; Irina Berger; Goetz M Richter
Journal:  J Vasc Interv Radiol       Date:  2009-12       Impact factor: 3.464

5.  The arterial distribution of Embozene and Embosphere microspheres in sheep kidney and uterus embolization models.

Authors:  Valentin Verret; Saïda Homayra Ghegediban; Michel Wassef; Jean Pierre Pelage; Jafar Golzarian; Alexandre Laurent
Journal:  J Vasc Interv Radiol       Date:  2011-02       Impact factor: 3.464

6.  Water-soluble polyvinyl alcohol microspheres for temporary embolization: development and in vivo characteristics in a pig kidney model.

Authors:  Yuzo Shomura; Noboru Tanigawa; Mitsuo Shibutani; Shinya Wakimoto; Kazutoshi Tsuji; Takanori Tokuda; Jiro Terada; Shuji Kariya; Hiroyuki Kojima; Atsushi Komemushi; Satoshi Sawada
Journal:  J Vasc Interv Radiol       Date:  2010-12-30       Impact factor: 3.464

Review 7.  Renal artery embolization: clinical indications and experience from over 100 cases.

Authors:  Michael J Schwartz; Eric B Smith; David W Trost; E Darracott Vaughan
Journal:  BJU Int       Date:  2006-12-13       Impact factor: 5.588

8.  Inflammation and recanalization of four different spherical embolization agents in the porcine kidney model.

Authors:  Sibylle Stampfl; Nadine Bellemann; Ulrike Stampfl; Boris Radeleff; Ruben Lopez-Benitez; Christof-Matthias Sommer; Heidi Thierjung; Irina Berger; Goetz M Richter
Journal:  J Vasc Interv Radiol       Date:  2008-04       Impact factor: 3.464

9.  Renal chemoembolization with mitomycin c/Ethibloc: pharmacokinetics and efficacy in an animal model.

Authors:  M Kurzidem; P Seidensticker; J Rassweiler
Journal:  J Endourol       Date:  2002-09       Impact factor: 2.942

10.  Effect of renal embolization with trisacryl and PAVc.

Authors:  Leandro de Assis Barbosa; Jose Guilherme Mendes Pereira Caldas; Mario Luiz Conti; Denise Maria Avancini Costa Malheiros; Francisco Ferreira Ramos
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more
  4 in total

1.  Transarterial chemoembolization of unresectable renal cell carcinoma with doxorubicin-loaded CalliSpheres drug-eluting beads.

Authors:  Yonghua Bi; Xiaonan Shi; Jianzhuang Ren; Mengfei Yi; Xinwei Han
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

2.  Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres® Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Bin Liang; Joyman Makamure; Shenglei Shu; Lijie Zhang; Tao Sun; Chuansheng Zheng
Journal:  Front Oncol       Date:  2021-03-16       Impact factor: 6.244

3.  Callispheres drug-eluting bead transhepatic artery chemoembolization with oral delivery of sorafenib for the treatment of unresectable liver cancer.

Authors:  Wenhui Wang; Fenqiang Li; Peiying Gan; Baohua Li; Shuangxi Li
Journal:  Front Surg       Date:  2022-09-02

4.  Assessment of efficacy and safety by CalliSpheres versus HepaSpheres for drug-eluting bead transarterial chemoembolization in unresectable large hepatocellular carcinoma patients.

Authors:  Guangsheng Zhao; Song Liu; Songbai Chen; Zhizhong Ren; Chuang Li; Jie Bian; Jianlin Wu; Jun Zhou; Yuewei Zhang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.